Clinical Trials – Xennials Therapeutics,

XNTR-20-02: Phase 1a: Open-label, dose-exploration study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of NTX-301 …, XNTR-20-02: Phase 1a: Open-label, dose-exploration study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of NTX-301 …, Read More

Scroll to Top